Mark Ross Middleton (Mark Middleton, Mark R Middleton)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 38

Top Topics

Gene Expression

Prognostic Factors

Monoclonal Antibody

Top Venues

Journal for immunotherapy of cancer

Nature medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Robert A Watson, Weiyu Ye, Chelsea A Taylor, Elsita Jungkurth, Rosalin Cooper, Orion Tong, Tim James, Brian Shine, Monika Hofer, Damian Jenkins, Robert Pell, Eleni Ieremia, Stephanie Jones, David Maldonado-Perez, Ian S D Roberts, Nicholas Coupe, Mark Ross Middleton, Miranda J Payne, Benjamin P Fairfax
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for immunotherapy of cancer 12 (4) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Robert A Watson, Weiyu Ye, Chelsea A Taylor, Elsita Jungkurth, Rosalin Cooper, Orion Tong, Tim James, Brian Shine, Monika Hofer, Damian Jenkins, Robert Pell, Eleni Ieremia, Stephanie Jones, David Maldonado-Perez, Ian S D Roberts, Nicholas Coupe, Mark Ross Middleton, Miranda J Payne, Benjamin P Fairfax
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for immunotherapy of cancer 12 (4) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Robert A Watson, Weiyu Ye, Chelsea A Taylor, Elsita Jungkurth, Rosalin Cooper, Orion Tong, Tim James, Brian Shine, Monika Hofer, Damian Jenkins, Robert Pell, Eleni Ieremia, Stephanie Jones, David Maldonado-Perez, Ian S D Roberts, Nicholas Coupe, Mark Ross Middleton, Miranda J Payne, Benjamin P Fairfax
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for immunotherapy of cancer 12 (4) (2024)
Omid Hamid, Karl D Lewis, Amy Weise, Meredith A McKean, Kyriakos P Papadopoulos, John Crown, Tae Min Kim, Dae Ho Lee, Sajeve S Thomas, Janice Mehnert, John Kaczmar, Nehal J Lakhani, Kevin B Kim, Mark Ross Middleton, Guilherme Rabinowits, Alexander I Spira, Melinda Yushak, Inderjit Mehmi, Fang Fang, Shuquan Chen, Jayakumar Mani, Vladimir Jankovic, Fang Wang, Nathalie Fiaschi, Laura Brennan, Anne J Paccaly, Sheila Masinde, Mark Salvati, Matthew G Fury, Glenn S Kroog, Israel Lowy, Giuseppe Gullo
Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Robert A Watson, Weiyu Ye, Chelsea A Taylor, Elsita Jungkurth, Rosalin Cooper, Orion Tong, Tim James, Brian Shine, Monika Hofer, Damian Jenkins, Robert Pell, Eleni Ieremia, Stephanie Jones, David Maldonado-Perez, Ian S D Roberts, Nicholas Coupe, Mark Ross Middleton, Miranda J Payne, Benjamin P Fairfax
Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for immunotherapy of cancer 12 (4) (2024)
Jason John Luke, Diwakar Davar, Robert H Andtbacka, Nina Bhardwaj, Joshua D Brody, Jason A Chesney, Robert Coffin, Thierry de Baere, Tanja D de Gruijl, Matthew Fury, Gregory Goldmacher, Kevin J Harrington, Howard Kaufman, Ciara M Kelly, Anuradha D Khilnani, Ke Liu, Sherene Loi, Georgina V Long, Ignacio Melero Bermejo, Mark Ross Middleton, Bart Neyns, David James Pinato, Rahul A Sheth, Stephen B Solomon, Philippe Szapary, Aurélien Marabelle
Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease. Journal for immunotherapy of cancer 12 (4) (2024)
Curigliano Giuseppe, Geoffrey I Shapiro, Rebecca S Kristeleit, Albiruni R Abdul Razak, Stephen Leong, Maria Alsina, Antonio Giordano, Karen A Gelmon, Erica Stringer-Reasor, Ulka N Vaishampayan, Mark Ross Middleton, Anthony J Olszanski, Hope S Rugo, Kenneth A Kern, Nuzhat Pathan, Rachelle Perea, Kristen J Pierce, Sarah C Mutka, Zev A Wainberg
Correction to: A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. British journal of cancer (2023)
Omid Hamid, Jessica C Hassel, Alexander N Shoushtari, Friedegund Meier, Todd M Bauer, April K S Salama, John M Kirkwood, Paolo Antonio Ascierto, Paul C Lorigan, Cornelia Mauch, Marlana Orloff, Thomas R Jeffry Evans, Chris Holland, Ramakrishna Edukulla, Shaad E Abedin, Mark Ross Middleton
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study. Journal for immunotherapy of cancer 11 (6) (2023)
James M G Larkin, Michele Del Vecchio, Mario Mandala, Helen J Gogas, Ana M Arance, Stéphane Dalle, Charles Lance Cowey, Michael Schenker, Jean-Jacques Grob, Vanna Chiarion Sileni, Ivan Marquez-Rodas, Marcus O Butler, Anna Maria Di Giacomo, Mark Ross Middleton, Jose Lutzky, Luis de la Cruz Merino, Petr Arenberger, Victoria Atkinson, Andrew G Hill, Leslie A Fecher, Michael Millward, Paul D Nathan, Nikhil I Khushalani, Paola Queirolo, Corey Ritchings, Maurice Lobo, Margarita Askelson, Hao Tang, Sonia Dolfi, Paolo Antonio Ascierto, Jeffrey S Weber
Adjuvant Nivolumab Versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results From CheckMate 238. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Curigliano Giuseppe, Geoffrey I Shapiro, Rebecca S Kristeleit, Albiruni R Abdul Razak, Stephen Leong, Maria Alsina, Antonio Giordano, Karen A Gelmon, Erica Stringer-Reasor, Ulka N Vaishampayan, Mark Ross Middleton, Anthony J Olszanski, Hope S Rugo, Kenneth A Kern, Nuzhat Pathan, Rachelle Perea, Kristen J Pierce, Sarah C Mutka, Zev A Wainberg
A Phase 1B open-label study of gedatolisib (PF-05212384) in combination with other anti-tumour agents for patients with advanced solid tumours and triple-negative breast cancer. British journal of cancer (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Manik Garg, Dominique-Laurent Couturier, Jeremie Nsengimana, Nuno A Fonseca, Matthew J Wongchenko, Yibing Yan, Martin Lauss, Göran B Jönsson, Julia Newton-Bishop, Christine Parkinson, Mark Ross Middleton, D Timothy Timothy Bishop, Sarah McDonald, Nikki Stefanos, John A Tadross, Ismael A Vergara, Serigne N Lô, Felicity Newell, James S Wilmott, John F Thompson, Georgina V Long, Richard A Scolyer, Pippa Corrie, David J Adams, Alvis Brazma, Roy Rabbie
Author Correction: Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nature communications 13 (1) (2022)
Denis Horgan, Anne-Marie Baird, Mark Ross Middleton, Zhasmina Mihaylova, Jan P Van Meerbeeck, Jens Vogel-Claussen, Paul E Y Van Schil, Josep Malvehy, Paolo Antonio Ascierto, France Dube, Michael Zaiac, Jonathan A Lal, Grażyna Kamińska-Winciorek, Marco Donia, Thierry André, Marta Kozaric, Pia J Osterlund, Dan Lucian Dumitrascu, Lorenzo Spaggiari
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma? Healthcare (Basel, Switzerland) 10 (9) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Chelsea Alice Taylor, Robert A Watson, Orion Tong, Weiyu Ye, Isar Nassiri, James J Gilchrist, Alba Verge de Los Aires, Piyush Kumar Sharma, Surya Koturan, Rosalin A Cooper, Victoria K Woodcock, Elsita Jungkurth, Brian Shine, Nicholas Coupe, Miranda J Payne, David N Church, Vivek Naranbhai, Stefan Groha, Paul Emery, Kulveer Mankia, Matthew L Freedman, Toni K Choueiri, Mark Ross Middleton, Alexander Gusev, Benjamin P Fairfax
IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma. Nature medicine 28 (12) (2022)
Vinton W T Cheng, Nicholas de Pennington, Rasheed Zakaria, James R Larkin, Sébastien Serres, Manjima Sarkar, Matthew A Kirkman, Claire Bristow, Paula Croal, Puneet Plaha, Leticia Campo, Michael A Chappell, Simon R Lord, Michael D Jenkinson, Mark Ross Middleton, Nicola R Sibson
VCAM-1-targeted MRI Improves Detection of the Tumor-brain Interface. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
Shivan Sivakumar, Enas Abu Shah, David J Ahern, Edward H Arbe-Barnes, Ashwin K Jainarayanan, Nagina Mangal, Srikanth Reddy, Aniko Rendek, Alistair Easton, Elke Kurz, Michael Silva, Zahir Soonawalla, Lara Rosaline Heij, Rachael J M Bashford-Rogers, Mark Ross Middleton, Michael L Dustin
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer. Cancers 13 (8) (2021)
Jonathan C M Wan, Katrin Heider, Davina Gale, Suzanne Murphy, Eyal Fisher, Florent Mouliere, Andrea Ruiz-Valdepenas, Angela Santonja, James Morris, Dineika Chandrananda, Andrea Marshall, Andrew B Gill, Pui Ying Chan, Emily Barker, Gemma Young, Wendy N Cooper, Irena Hudecova, Francesco Marass, Richard Mair, Kevin M Brindle, Grant D Stewart, Jean E Abraham, Carlos Caldas, Doris M Rassl, Robert C Rintoul, Constantine Alifrangis, Mark Ross Middleton, Ferdia A Gallagher, Christine Parkinson, Amer Durrani, Ultan McDermott, Christopher G Smith, Charles E Massie, Philippa Corrie, Nitzan Rosenfeld
ctDNA monitoring using patient-specific sequencing and integration of variant reads. Science translational medicine 12 (548) (2021)
Weiyu Ye, Anna Olsson-Brown, Robert A Watson, Vincent T F Cheung, Robert D Morgan, Isar Nassiri, Rosalin Cooper, Chelsea A Taylor, Umair Akbani, Oliver Brain, Rubeta N Matin, Nicholas Coupe, Mark Ross Middleton, Mark Coles, Joseph J Sacco, Miranda J Payne, Benjamin P Fairfax
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British journal of cancer 124 (10) (2021)
Mitchell E Fane, Brett L Ecker, Amanpreet Kaur, Gloria E Marino, Gretchen M Alicea, Stephen M Douglass, Yash Chhabra, Marie R Webster, Andrea Marshall, Richard Colling, Olivia Espinosa, Nicholas Coupe, Neera Maroo, Leticia Campo, Mark Ross Middleton, Philippa Corrie, Xiaowei Xu, Giorgos C Karakousis, Ashani T Weeraratna
sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (21) (2021)
Manik Garg, Dominique-Laurent Couturier, Jeremie Nsengimana, Nuno A Fonseca, Matthew J Wongchenko, Yibing Yan, Martin Lauss, Göran B Jönsson, Julia Newton-Bishop, Christine Parkinson, Mark Ross Middleton, D Timothy Timothy Bishop, Sarah McDonald, Nikki Stefanos, John A Tadross, Ismael A Vergara, Serigne N Lô, Felicity Newell, James S Wilmott, John F Thompson, Georgina V Long, Richard A Scolyer, Pippa Corrie, David J Adams, Alvis Brazma, Roy Rabbie
Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nature communications 12 (1) (2021)
Robert A Watson, Orion Tong, Rosalin A Cooper, Chelsea Alice Taylor, Piyush Kumar Sharma, Alba Verge de Los Aires, Elise A Mahé, Hélène Ruffieux, Isar Nassiri, Mark Ross Middleton, Benjamin P Fairfax
Immune checkpoint blockade sensitivity and progression-free survival associates with baseline CD8+ T cell clone size and cytotoxicity. Science immunology 6 (64) (2021)
Mark Ross Middleton, Christoph Hoeller, Olivier Michielin, Caroline Robert, Caroline Caramella, Katarina Öhrling, Axel Hauschild
Intratumoural immunotherapies for unresectable and metastatic melanoma: current status and future perspectives. British journal of cancer 123 (6) (2020)
Mark Ross Middleton, Cheryl McAlpine, Victoria K Woodcock, Philippa Corrie, Jeffrey R Infante, Neil M Steven, Thomas R Jeffry Evans, Alan Anthoney, Alexander N Shoushtari, Omid Hamid, Avinash Gupta, Antonella Vardeu, Emma Leach, Revashnee Naidoo, Sarah Stanhope, Sion Lewis, Jacob Hurst, Ita O'Kelly, Mario Sznol
Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Benjamin P Fairfax, Chelsea A Taylor, Robert A Watson, Isar Nassiri, Sara Danielli, Hai Fang, Elise A Mahé, Rosalin Cooper, Victoria K Woodcock, Zoe Traill, M Hussein Al-Mossawi, Julian C Knight, Paul Klenerman, Miranda Payne, Mark Ross Middleton
Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma. Nature medicine 26 (2) (2020)
Carla Solé, Daniela Tramonti, Maike Schramm, Ibai Goicoechea, María Armesto, Luiza I Hernandez, Lorea Manterola, Marta Fernández-Mercado, Karmele Mujika, Anna Tuneu, Ane Jaka, Maitena Tellaetxe-Abete, Marc R Friedländer, Xavier Estivill, Paolo Piazza, Pablo Luis Ortiz-Romero, Mark Ross Middleton, Charles H Lawrie
The Circulating Transcriptome as a Source of Biomarkers for Melanoma. Cancers 11 (1) (2019)
Richard Peter Owen, Michael Joseph White, David Tyler Severson, Barbara Braden, Adam Bailey, Robert Goldin, Lai Mun Wang, Carlos Ruiz-Puig, Nicholas David Maynard, Angie Green, Paolo Piazza, David Buck, Mark Ross Middleton, Chris Paul Ponting, Benjamin Schuster-Boeckler, Xin Lu
Single cell RNA-seq reveals profound transcriptional similarity between Barrett's oesophagus and oesophageal submucosal glands. Nature communications 9 (1) (2018)
Vinton W T Cheng, Manuel Sarmiento Soto, Alexandre A Khrapitchev, Francisco Perez-Balderas, Rasheed Zakaria, Michael D Jenkinson, Mark Ross Middleton, Nicola R Sibson
VCAM-1-targeted MRI Enables Detection of Brain Micrometastases from Different Primary Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (2) (2018)